Abstract:Qinghe Zeng, 1, 2, &ast Qi Sun, 3, &ast Huihui Xu, 1, 2, &ast Jiali Chen, 1 Houfu Ling, 4 Qinwen Ge, 1, 2 Kaiao Zou, 1, 2 Xu Wang, 1, 2 Hongting Jin, 1 Ju Li, 4, &ast Minwei Jin 4, &ast 1 Institute of Orthopedics and Traumatology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 The First College of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 3 Department of Orthopaedic Surgery, Fuyang Orthopaedics and Traumatology Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China; 4 Department of Orthopaedics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Minwei Jin; Ju Li, Email ; Background: Intervertebral disc degeneration (IDD) is a major cause of lower back pain (LBP), in which inflammatory is frequently involved. Amygdalin (AMD) is a naturally occurring compound that exerts anti-fibrotic, anti-inflammatory, analgesic, and immunomodulatory effects in various diseases. The purpose of this study was to investigate the therapeutic effects and molecular mechanisms of AMD on Lumbar spine instability (LSI)-induced IDD in mice. Methods: In this study, we first explored the effects of AMD in vivo, and then further explored the mechanism of its effects both in vivo and in vitro. Ten-week-old male C57BL/6J mice were administrated with AMD. At 10 weeks after LSI, spinal were collected for tissue analyses, including histology, micro-CT, and immunohistochemistry for Col2, Mmp-13, TNF-α, and p-P65. Additionally, we also evaluated the mRNA and protein expression level of p-P65 and p-IKBα after being treated with AMD in vitro. Results: Histological staining, micro-CT and immunohistochemical analysis showed that AMD treatment significantly inhibited the expression of TNF-α and Mmp-13, increased the expression of Col2 as well as attenuated the calcification of cartilage endplates, eventually to delayed the progression of IDD. Meanwhile, in vivo and in vitro fluorescence imaging revealed that AMD markedly inhibited the AMD significantly inhibited the LSI-induced increase in TNF-α expression and P65and IKBα phosphorylation. Discussion: Our findings suggest that AMD partly inhibits the activation of NF-κB signaling pathway to reduce the release of inflammatory mediators and delay the degeneration of cartilage endplate in IDD model mice. Therefore, AMD may be a potential candidate for the treatment of IDD. Keywords: intervertebral disc degeneration, amygdalin, cartilage endplate, inflammatory processes, NF-κB pathway Low back pain (LBP) is one of the common orthopaedic diseases in daily life, and its prevalence is increasing with age, and it is also related to excessive exercise. 1,2 This not only affects people's quality of life but also increases the burden of social medical resources. 3 As research has found, disc degeneration is closely linked to LBP and is one of the main causes of LBP. 4 However, the exact mechanism of Intervertebral disc degeneration (IDD) has not yet been elucidated. 5 The intervertebral disc (IVD) is a fibrocartilaginous disc between two adjacent pyramids, consisting of the nucleus pulposus (NP), the annulus fibrosus (AF), and the upper and lower cartilage endplates (CEP). Modern studies have found that IDD is mainly manifested in the reduction of the number of NP cells, abnormal ECM metabolism, reduction of type II collagen, and calcification and death of endplate chondrocytes, etc. 6 Nowadays, the therapeutic strategies to treat IVD degeneration and assuage IDD-related pain include conservative treatments, such as anti-inflammatory drugs. When these treatments prove themselves inefficient, radical surgical interventions (eg disc removal and spinal fusion) are considered. These changes are closely related to the inflammatory response mediated by cellular inflammatory factors. Inflammation not only reduces the synthesis of extracellular matrix such as proteoglycans and type II collagen but also promotes the expression of matrix metalloproteinases (MMPs), which further reduces the biological properties of cartilage endplates and eventually leads to IDD. 7–9 For example, administration of Chlorogenic Acid (CGA) mitiga -Abstract Truncated-

Curcumenol Mitigates the Inflammation and Ameliorates the Catabolism Status of the Intervertebral Discs In Vivo and In Vitro via Inhibiting the TNFα/NFκB Pathway

Curcumenol Mitigates the Inflammation and Ameliorates the Catabolism Status of the Intervertebral Discs <i>In Vivo</i> and<i> In Vitro via</i> Inhibiting the TNFa/NF?B Pathway

Curcumol Alleviates the Inflammation of Nucleus Pulposus Cells Via the PI3K/Akt/NF-κB Signaling Pathway and Delays Intervertebral Disk Degeneration

Curcumol Alleviates the Inflammation of Nucleus Pulposus Cells via the PI3K/Akt/NF-κB Signaling Pathway and Delays Intervertebral Disk Degeneration.

Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors

Curculigoside Upregulates BMAL1 to Decrease Nucleus Pulposus Cell Apoptosis by Inhibiting the JAK/STAT3 Pathway

Curcumenol mitigates chondrocyte inflammation by inhibiting the NF-B and MAPK pathways, and ameliorates DMM-induced OA in mice

Curcumenol mitigates chondrocyte inflammation by inhibiting the NF‐κB and MAPK pathways, and ameliorates DMM‐induced OA in mice

Baicalein Inhibits the IL-1β-Induced Inflammatory Response in Nucleus Pulposus Cells and Attenuates Disc Degeneration in Vivo.

Cardamonin protects nucleus pulposus cells against IL-1-induced inflammation and catabolism <i>via</i> Nrf2/NF-B axis

Honokiol Alleviates the Degeneration of Intervertebral Disc Via Suppressing the Activation of TXNIP-NLRP3 Inflammasome Signal Pathway.

Cardamonin protects nucleus pulposus cells against IL-1β-induced inflammation and catabolism via Nrf2/NF-κB axis.

Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration

Procyanidin B3 Alleviates Intervertebral Disc Degeneration Via Interaction with the TLR4/MD-2 Complex.

Lycorine Suppresses Endplate-Chondrocyte Degeneration and Prevents Intervertebral Disc Degeneration by Inhibiting NF-κB Signalling Pathway

CB2-mediated Attenuation of Nucleus Pulposus Degeneration Via the Amelioration of Inflammation and Oxidative Stress in Vivo and in Vitro.

Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK

Amygdalin Delays Cartilage Endplate Degeneration and Improves Intervertebral Disc Degeneration by Inhibiting NF-κB Signaling Pathway and Inflammatory Response

Urolithin A Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in vivo

Mesoporous Silica Nano-Particles Based Arctigenin (MSN-ARC-G) Attenuates Intervertebral Disc Degeneration (IVDD) and Inflammation in Mice and Human NP Cells by Suppressing the MAPK/ERK Pathway

Inactivation of Tnf-α/Tnfr signaling attenuates progression of intervertebral disc degeneration in mice